Trial Capacity Award Recipients 

More clinical trials and more participants mean more opportunities to find new treatments and a cure for ALS. We are proud to support established and emerging sites like these through our Trial Capacity Awards as they work to improve trial accessibility for people with ALS and the efficiency and pace at which this research is conducted.    

2023 Recipients 

Dave Arnold​, M.D., University of Missouri-Columbia​
ALS Clinical Trial Readiness in Rural Missourians​ 

Sarah Berth​, M.D., Ph.D., Baylor College of Medicine​
Development of an ALS Clinical Trials Program at Baylor College of Medicine​ 

Dominic Fee​, M.D., The Medical College​ of Wisconsin​
Enhancing ALS Clinical Trials at the​ Medical College of Wisconsin​ 

Noam Harel​, M.D., Ph.D., Bronx Veterans Medical Research Foundation​
Integrating Research Capacity into the James J. Peters Veterans ALS Clinic​ 

Liberty Jenkins​, M.D., California Pacific Medical Center & Forbes Norris MDA/ALS Research Center​
Creating a Research Navigator Role​ to Increase Trial Participation​ 

LEARN MORE ABOUT OUR 2023 RECIPIENTS

2022 Recipients 

Ximena Arcila-Londono, M.D., Henry Ford Health System
Harry J Hoenselaar ALS Clinic, Henry Ford Health Systems Detroit Proposal  

Laura Foster, M.D., University of Colorado Denver
Rocky Mountain ALS Trials: Underserved & Genetic Population Optimization  

Stephen Goutman, M.D., University of Michigan
Increasing ALS Clinical Trial Capacity at University of Michigan  

Terry Heiman-Patterson, M.D., Temple University 
Enhancement of Trial Capacity at Temple University ALS Center of Hope  

Hristelina Ilieva, M.D., Ph.D., Thomas Jefferson University
Improving and Expanding Access to Clinical Trials in the Tri-State Region  

Stephen Johnson, M.D., Mayo Clinic Arizona
Mayo Clinic Scottsdale Clinical Trial Capacity Expansion  

Stephen James Kolb, M.D., Ph.D., The Ohio State University
Ohio State ALS Clinical Trial Access and Capacity Leadership  

Eduardo Locatelli, M.D., MPH, Nova Southeastern University
ALS Clinical Trial Expansion to Hispanic Populations in South Florida  

Neil Shneider, M.D., Ph.D., Columbia University
Diversity and Inclusion in ALS Research throughout Greater New York  

Jeffrey Statland, M.D., University of Kansas Medical Center Research Institute
Increasing Trial Accessibility in Underserved Populations  

Jackie Whitesell, M.D., Saint Alphonsus Regional Medical Center Research Institute  
Saint Alphonsus ALS Trial Expansion  

Valerie Wojna, M.D., University of Puerto Rico  
Caribbean Hispanic Amyotrophic Lateral Sclerosis Center for Clinical Trials  

Abel Wu, M.D., Kaiser Foundation Research Institute, a Division of Kaiser Foundation Hospitals  
Increasing Kaiser Permanente Southern California ALS Clinical Trial Capacity

LeARN MORE ABOUT OUR 2022 RECIPIENTS

Print Friendly and PDF